It’s time to stop ignoring lung cancer
By Joanna Moorhead – The Guardian. Thirty percent of people with lung cancer will die…
Browsing: Lung Cancer
UK pharmacists streamline experimental cancer trials
A new way of conducting technical pharmacy reviews that cuts down on the bureaucracy of…
Phase III trial results raise questions about the future of lung cancer vaccination
Experts are divided on the value of lung cancer vaccination after disappointing results from the…
Curcumin, special peptides boost cancer-blocking PIAS3 to neutralize STAT3 in mesothelioma
A common Asian spice and cancer-hampering molecules show promise in slowing the progression of mesothelioma,…
Marker found in one in six people could give higher risk of lung and other cancers
Cancer Research UK scientists have discovered why a gene fault found in around one in…
Research demonstrates potential method to better control lung cancer using radiotherapy
UK scientists are working out how to safely increase the radiotherapy dose given to lung…
Online screening for rare lung cancer subtypes opens door to new kind of clinical trial
In the previous few years, several breakthrough treatments have become available for key subtypes of…
New gene discovered that stops the spread of deadly cancer
Scientists identify gene that fights metastasis of a common lung cancerntify gene that fights metastasis…
Astra-Zeneca cancer drug hailed as ‘great white hope’ in fight against illness
Source: The Guardian – Rupert Neate. Drug MEDI4736 fast-tracked to phase-III trials following tests on…
Poor quality of life doesn’t predict low survival rates in high-risk lung cancer patients undergoing surgery
High-risk operable lung cancer patients have poorer quality of life scores than the normal U.S.…